(Q64151777)

English

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Phase I Study of Intraventricular Infusions of Autologous Ex Vivo-Expanded NK Cells in Children With Recurrent/Refractory Malignant Posterior Fossa Tumors of the Central Nervous System. NOAH's (New Opportunity, Advancing Hope) Protocol (English)

0 references

0 references

0 references

United States of America

0 references

start time

17 March 2015

0 references

end time

30 March 2020

0 references

number of participants

24

0 references

clinical trial phase

phase I clinical trial

0 references

maximum age

21 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02271711

0 references

(Q64151777)

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)